ZYDUSLIFE Zydus Lifesciences Ltd Other Situations Announcement 2025 - Zydus-CVS Agreement Zydus Lifesciences Ltd has partnered with CVS Caremark to include ZituvioTM, ZituvimetTM, and ZituvimetTM XR in its formulary, effective January 1, 2025, enhancing access to treatments for type 2 diabetes. The U.S. market for DPP-IV inhibitors and their combinations is valued at $10 billion according to IQVIA..Find Corporate Announcements for Press Releases, AGM, Insider Trading & SAST, Results and Corporate Action for Zydus Lifesciences Ltd